Locations:
Search IconSearch

News & Insight

TFRT_650x450
March 22, 2019/Cancer/News & Insight

Time-to-Treat, Two Years Later

Our Cancer Center Chair reflects on progress and potential

Blood test
February 20, 2019/Cancer/News & Insight

Expertise in Rare Cancers and Blood Disorders

From amyloidosis to small cell bladder cancer

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20496714399_9d12e253e1_z_650x450
February 4, 2019/Cancer/News & Insight

Electronic Brachytherapy: Is It a Viable Option?

Why experts advise against it for breast, skin and gynecologic cancers

Castleman disease
December 19, 2018/Cancer/News & Insight

Treatment Guidelines Established for Idiopathic Multicentric Castleman Disease

An international consensus statement on a subtype of a rare disease

literature_650x450
December 13, 2018/Cancer/News & Insight

Drop the Jargon: Speak Plainly to Patients

How medical jargon inhibits patient understanding

Breast-cancer_650x450
December 5, 2018/Cancer/News & Insight

Adjuvant T-DM1 Superior to Trastuzumab in Patients with HER2+ Early Breast Cancer

Increased invasive disease-free survival, disease-free survival and overall survival

pancreatic-cancer_650x450
November 21, 2018/Cancer/News & Insight

ASCO Updates Guidelines for Patients with Metastatic Pancreatic Cancer

New recommendations for second-line therapy

Ortega, MD
November 16, 2018/Cancer/News & Insight

Why Ears Are More Important than Stethoscopes

Doctors called to heal, not just treat

BackPage 10 of 13Next

Advertisement

Ad